T1	Participants 410 449	patients with severe acute pancreatitis
T2	Participants 459 521	One hundred seventy-six patients with necrotizing pancreatitis
T3	Participants 1115 1146	patients treated with meropenem
T4	Participants 1151 1178	those treated with imipenem
T5	Participants 1396 1435	patients with severe acute pancreatitis
